# Thvc
THVC is a San Francisco, California-based venture capital manager that invests in healthcare companies. Its fund vehicles are managed by Transformational Healthcare GP, LLC, with Darren F. Hite signing the SEC filings as Managing Director; the THVC (Zoe C) vehicle, for example, was filed with the US Securities and Exchange Commission (SEC) as a Delaware limited liability company on November 3, 2022.[1](https://www.sec.gov/Archives/edgar/data/1949024/0001949024-22-000001.txt) • [2](https://www.cbinsights.com/investor/thvc)
| Key fact | Detail |
|---|---|
| Type | Venture capital manager, healthcare sector[2](https://www.cbinsights.com/investor/thvc) |
| Headquarters | 2384 Union Street, San Francisco, CA 94123 (filing address)[1](https://www.sec.gov/Archives/edgar/data/1949024/0001949024-22-000001.txt) |
| Manager | Transformational Healthcare GP, LLC[1](https://www.sec.gov/Archives/edgar/data/1949024/0001949024-22-000001.txt) |
## History and people
The firm's SEC filings identify Darren F. Hite as the Managing Director of Transformational Healthcare GP, LLC, the manager of the THVC (Zoe C) fund vehicle; Hite signed the THVC (Zoe C) Form D both for the manager and for the issuer, THVC (Zoe C), LLC, on November 3, 2022.[1](https://www.sec.gov/Archives/edgar/data/1949024/0001949024-22-000001.txt) The THVC (Zoe C) filing lists Transformational Healthcare GP, LLC at the same 2384 Union Street address as its promoter and manager.[1](https://www.sec.gov/Archives/edgar/data/1949024/0001949024-22-000001.txt)
Directory profiles indicate THVC was founded in 2016 by Darren Hite and describe a model of partnering with select family offices to fund healthcare companies; this founding date and model are unverified beyond aggregator data.[2](https://www.cbinsights.com/investor/thvc)
## Funds, by the numbers
THVC filed the THVC (Zoe C) vehicle as a separate Delaware limited liability company, registered under Investment Company Act Section 3(c)(7) and identified in the filing as a Venture Capital Fund.[1](https://www.sec.gov/Archives/edgar/data/1949024/0001949024-22-000001.txt) The THVC (Zoe C) vehicle reported a total offering amount of $5,250,000, all of it sold to 4 investors.[1](https://www.sec.gov/Archives/edgar/data/1949024/0001949024-22-000001.txt)
| Vehicle | Amount sold | First sale filed |
|---|---|---|
| THVC (Zoe C), LLC | $5,250,000 | October 2022 |
The amount and date come from the firm's SEC Form D filing.[1](https://www.sec.gov/Archives/edgar/data/1949024/0001949024-22-000001.txt) No source explains how the firm's vehicles are funded or governed beyond what the filings show.
## Portfolio and investments
Cionic announced a $12 million Series A extension on October 18, 2023, led by [L Catterton](https://www.edgepedia.org/l-catterton) with new investor THVC and Enable Ventures as a partner; with $12.5 million raised in September 2021, the extension brought Cionic's Series A to $25 million, though THVC's own investment amount was not disclosed.[3](https://www.finsmes.com/2023/10/cionic-raises-12m-in-series-a-extension-funding.html) This figure comes from VatorNews reporting reproduced on an aggregator profile and is unverified against primary sources.[2](https://www.cbinsights.com/investor/thvc)
The same profile tracks 5 THVC investments dated September 2020, May 2021, January 2022, April 2023, and October 2023, with only the Cionic amount disclosed; this tracking is likewise unverified directory data.[2](https://www.cbinsights.com/investor/thvc)
## References
1. SEC Form D — THVC (Zoe C), LLC, filed 2022-11-03. https://www.sec.gov/Archives/edgar/data/1949024/0001949024-22-000001.txt
2. THVC Portfolio Investments, THVC Funds, THVC Exits (CB Insights, incorporating VatorNews reporting). https://www.cbinsights.com/investor/thvc
3. Cionic raises 12m in series a extension funding (finsmes.com). https://www.finsmes.com/2023/10/cionic-raises-12m-in-series-a-extension-funding.html
---
*Topic: Encyclopedia › Society and history › Economics and business › Finance › Venture capital and private equity › Venture capital firms of the Americas › Healthcare and life sciences investors*
*Initially written Sep 17, 2026 · Reviewed: Sep 20, 2026; Sep 30, 2026 · Edited: Sep 30, 2026; Oct 11, 2026 · Last review: Sep 30, 2026*
*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*
License: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license